✦ LIBER ✦

Treatment of relapsed and refractory myeloma

✍ Scribed by Jonathan Kaufman; Charise Gleason; Sagar Lonial

Publisher: Current Science Inc.
Year: 2009
Tongue: English
Weight: 372 KB
Volume: 4
Category: Article
ISSN: 1558-8211
DOI: 10.1007/s11899-009-0014-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of relapsed and refractory mul

Treatment of relapsed and refractory multiple myeloma

✍ Seema Singhal; Jayesh Mehta 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 420 KB

A phase I safety study of enzastaurin pl

A phase I safety study of enzastaurin plus bortezomib in the treatment of relapsed or refractory multiple myeloma

✍ Irene M. Ghobrial; Nikhil C. Munshi; Brianna N. Harris; Peipei Shi; Nichole M. P 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 2 views

A modified regimen of pegylated liposoma

A modified regimen of pegylated liposomal doxorubicin, bortezomib, and dexamethasone is effective and well tolerated in the treatment of relapsed or refractory multiple myeloma

✍ Gabriel N. Waterman; Ori Yellin; Regina A. Swift; Russell Mapes; Benjamin Eades; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 206 KB

Bortezomib, doxorubicin, and dexamethaso

Bortezomib, doxorubicin, and dexamethasone combination therapy followed by thalidomide and dexamethasone consolidation as a salvage treatment for relapsed or refractory multiple myeloma: analysis of efficacy and safety

✍ Sung Sook Lee; Cheolwon Suh; Bong-Seog Kim; Jooseop Chung; Young-Don Joo; Hun-Mo 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 151 KB

A phase I study of bortezomib in combina

A phase I study of bortezomib in combination with doxorubicin and intermediate-dose dexamethasone (iPAD therapy) for relapsed or refractory multiple myeloma

✍ Yasushi Takamatsu; Kazutaka Sunami; Hiroyuki Hata; Koji Nagafuji; Ilseung Choi; 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 167 KB

Prolonged treatment with lenalidomide in

Prolonged treatment with lenalidomide in relapsed and refractory multiple myeloma

✍ Carlos Aguilar Franco; Luis Palomera; Jose Joaquín Ruiz Arredondo; Jesús Martín 📂 Article 📅 2011 🏛 Springer Healthcare Communications 🌐 English ⚖ 499 KB